Results 151 to 160 of about 42,587 (212)

Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls [PDF]

, 2009

core   +1 more source

Long-term survival outcomes of lorlatinib in advanced anaplastic lymphoma kinase (ALK)-fusion positive non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Morise M, Tanaka I, Ishii M.
europepmc   +1 more source

Cost-effectiveness of iruplinalkib versus crizotinib in first-line anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer patients in China. [PDF]

Front Pharmacol
Zhang W, Lu Y, Dai Z, Wang L, Zhou Y, Lu Y, Chang F.   +6 more
europepmc   +1 more source

Successful Pregnancies During Crizotinib Therapy for Anaplastic Lymphoma Kinase Positive Lymphoma. [PDF]

Hematol Oncol
Guglielmana V, Fusi FM, Giardini V, Cocito F, Gambacorti-Passerini C.   +4 more
europepmc   +1 more source

Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients. [PDF]

Thorac Cancer
Kim MJ, Kwak HS, Koh EN, Park CK, Kim YC, Oh IJ, Kim SJ, Lim JH, Ryu JS, Choi CM.   +9 more
europepmc   +1 more source

Severe skin toxicity and early progression following neoadjuvant ensartinib and surgery in anaplastic lymphoma kinase-positive locally advanced lung cancer: a case report. [PDF]

Front Pharmacol
Wang H, Li S, Wu Z, Xu W, Wang N, Xiao Z.   +5 more
europepmc   +1 more source

Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma [PDF]

, 2019
Clemens, Mark W., Hanson, Blake M., Hultgren, Scott J., Myckatyn, Terence M., Parikh, Rajiv, Pinkner, Chloe L., Pinkner, Jerome S., Simar, Shelby R., Walker, Jennifer N.   +8 more
core   +1 more source

Pharmacoeconomic Analysis of Brigatinib versus Alectinib in First‑Line Treatment of Anaplastic Lymphoma Kinase‑Positive Advanced Non‑Small‑Cell Lung Cancer in China. [PDF]

Oncol Ther
Chai Q, Gu C, Hernandez L, Zhang YJ.
europepmc   +1 more source

Immunologic pathomechanism of Hodgkin's lymphoma [PDF]

, 2017
Illés, Árpád, Jóna, Ádám, Szodoray, Péter   +2 more
core   +1 more source